Fig. 4

Overall survival: group 1 (cTACE) vs. group 2 (DEB-TACE), differentiated by status of portal invasion. P-values were 0.82 for patients with and 0.48 for patients without portal invasion. “I” denotes censored values
Overall survival: group 1 (cTACE) vs. group 2 (DEB-TACE), differentiated by status of portal invasion. P-values were 0.82 for patients with and 0.48 for patients without portal invasion. “I” denotes censored values